Amino Acids (AA)

Dynorphin A (1-9) H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-OH is a substrate binding inhibitor that blocks potassium channels. Dynorphin A (1-9) H-Tyr-Gly-Gly-Phe-Leu Arg Arg Ile Arg OH binds to the d -alanine site of the potassium channel and inhibits glutamate release from presynaptic terminals. Dynorphin A (1 9) H Tyr Gly Gly Phe Leu Arg Arg Ile Arg OH has been shown to be a potent inhibitor of aminopeptidase activity in vitro, which may be due to its affinity for the substrate binding site on the enzyme. Its inhibition of aminopeptidase activity may lead to an increase in opioid peptides such as dynorphins and enkephalins. Dynorphin A (1 9) H Tyr Gly Gly Phe

H-Thr-Arg-OH sulfate salt is a molecule that contains the active amino acid residues of vasoactive intestinal peptide (VIP) and reversed-phase high-performance liquid chromatography. The structure of VIP was determined by stepwise synthesis and chloromethyl ketone activation. It has been shown to have an intestinal effect, which is due to its ability to increase blood pressure. This drug also has potential as a therapeutic agent in the treatment of hypertension, heart disease, or diabetes mellitus.

Bz-Arg-OMe carbonate salt is a protease inhibitor that binds to the active site of serine proteases, inhibiting their activity. Bz-Arg-OMe carbonate salt has been shown to have inhibitory effects on Leishmania, a protozoan parasite. It is also an inhibitor of fibrinolysis, which may be due to its ability to bind calcium ions and serum albumin. Bz-Arg-OMe carbonate salt has affinity for carbohydrates and interacts with peptides.

Please enquire for more information about H-Asp-Ala-His-Lys-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (Des-Gly10,His(Bzl)6,Pro-NHEt 9)-LHRH including the price, delivery time and more detailed product information at the technical inquiry form on this page

Aspartame is a synthetic, sweetener that is used as a sugar substitute in diet products. It was discovered by accident in 1965 when James Schlatter, a chemist of G.D. Searle Company, was testing an anti-ulcer drug and l-phenylalanine methyl ester on his finger and tasted the sweetness on his fingers. Aspartame is composed of two amino acids: aspartic acid and phenylalanine. The aspartic acid is made up of a carboxylic acid group with an amide functional group. Aspartame can be found in many foods including chewing gum and diet sodas. It has been shown to have no carcinogenic effects or adverse effects on reproduction function in animal studies.

NFAT Inhibitor trifluoroacetate salt H-Met-Ala-Gly-Pro-His-Pro-Val-Ile-Val-Ile-Thr-Gly-Pro-His-Glu-Glu (NFAT) is an inhibitor drug that has been shown to inhibit the nuclear factor of activated T cells (NFAT). NFAT is a transcriptional regulator that controls the expression of inflammatory genes in macrophages and other cell types. NFAT inhibitors have been shown to be effective for treating bowel diseases, such as ulcerative colitis and Crohn's disease, by inhibiting the activation of macrophages. NFAT inhibitors are also used in vitro as a tool for studying cellular signaling pathways. The most common type of NFAT inhibitor is fluconazole, which blocks calcineurin activity and prevents the activation of NFAT. However, other types of inhibitors are being developed, including mmp9 activity or

Please enquire for more information about 2-(N-Phenyl-N-benzyl-aminomethyl)-imidazol including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Fmoc-Gln(Mtt)-OPfp including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Ac-Val-Tyr-Leu-Lys-Ala-SBzl including the price, delivery time and more detailed product information at the technical inquiry form on this page

Ac-Ala-Ala-Ala-Ala-OMe is a peptidase that hydrolyzes the ester bonds of the hydrophobic amino acid residues, such as alanine, valine, leucine, and isoleucine. This enzyme deacylates and releases these amino acids from the side chain of their corresponding fatty acyl groups. Ac-Ala-Ala-Ala-Ala-OMe also acts on N terminal and C terminal residues. The presence of a scissile bond in the peptide substrate is required for this enzyme to function. Acetylation reactions are concurrent with acylation reactions, which produce an acetylated peptide product.

H-[15N]Tyr-OH is a metabolite of tyrosine. It is the conjugate acid of propionic acid, and the conjugate base of 4-hydroxybenzyl. H-[15N]Tyr-OH is a phenylalanine and aromatic amino acid that has an aromatic ring with a phenyl substituent. This metabolite is hydroxy, which means it has one hydroxyl group on the phenyl ring. H-[15N]Tyr-OH binds to daphnia in vivo, causing death. The cause for this may be due to its ability to react with oxygen, forming reactive oxygen species (ROS).

BQ-123 is a cyclic peptide that has been shown to have a binding affinity for the serotonin receptor. The binding of BQ-123 to the receptor leads to a reduction in intracellular calcium concentration, which may be due to the inhibition of serine protease activity. This agent also inhibits the production of tumour necrosis factor-α (TNF-α) and has an inhibitory effect on cardiac contractility.